Form 4: InnovAge COO Jennifer Browne Receives RSU Grant

InnovAge Holding Corp. President and COO Jennifer Browne was granted 67,842 restricted stock units.

Summary

• Jennifer Browne, President and COO of InnovAge Holding Corp., acquired 67,842 restricted stock units (RSUs) on June 8, 2026.
• The RSUs were granted at a price of $0 per share.
• The units vest in three equal annual installments, contingent upon continued service with the company.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation that does not signal a change in company fundamentals.

Positives

• Alignment of executive interests with long-term shareholder value through equity-based compensation.

Negatives

• The grant results in potential future dilution for existing shareholders upon the settlement of the RSUs.

Risks

• Vesting is subject to the continued service of the executive, creating a retention dependency.

Future Outlook

The RSUs will vest in three equal annual installments, indicating a three-year retention horizon for the executive.

Industry Context

StockSavvy.ai notes that equity grants to C-suite executives are standard practice in the healthcare services sector to ensure leadership retention and align management incentives with corporate performance.

Comparison to Industry Standards

• The use of time-based RSU vesting schedules is consistent with standard corporate governance practices for publicly traded healthcare companies.
• The grant size is commensurate with typical executive compensation packages for a President and COO role in mid-cap healthcare firms.

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual conversion of these RSUs into common stock.

Next Steps

• Vesting of the first installment of RSUs on the first anniversary of the grant date.

Key Dates

Keywords

InnovAge, INNV, Insider Trading, Form 4, Executive Compensation, Restricted Stock Units